Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025)
Xtant Medical Holdings (XTNT) posted quarterly Cash from Investing Activities of $4.7 million for Q3 2025, up 332.9% year-over-year from $1.1 million in Q3 2024, and up 1576.03% quarter-over-quarter from -$317000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Cash from Investing Activities for 16 consecutive years, with $4.7 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Cash from Investing Activities rose 332.9% year-over-year to $4.7 million; the TTM figure through Sep 2025 stood at $2.7 million (up 148.43% YoY), while the FY2024 annual figure was -$3.7 million, up 84.95% from the prior year.
- Cash from Investing Activities grew to $4.7 million in Q3 2025 per XTNT's latest filing, from -$317000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $4.7 million in Q3 2025 and bottomed at -$17.4 million in Q1 2023.
- Historically, Cash from Investing Activities has averaged -$1.5 million across 5 years, with a median of -$483000.0 in 2021.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities slumped 4355.5% — and 2025, when it surged 332.9%.
- Xtant Medical Holdings' Cash from Investing Activities stood at -$595000.0 in 2021, then gained by 29.08% to -$422000.0 in 2022, then tumbled by 448.1% to -$2.3 million in 2023, then surged by 75.49% to -$567000.0 in 2024, then surged by 925.22% to $4.7 million in 2025.
- Business Quant data shows XTNT's Cash from Investing Activities at $4.7 million in Q3 2025, -$317000.0 in Q2 2025, and -$1.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Xtant Medical Holdings | 45.04 Mn | 27.44 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.68 Mn |
| Sep 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | -317,000.00 |
| Jun 30, 2025 | -317,000.00 |
| Mar 31, 2025 | -1.14 Mn |
| Mar 31, 2025 | -1.14 Mn |
| Dec 31, 2024 | -567,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Sep 30, 2024 | -2.01 Mn |
| Sep 30, 2024 | -2.01 Mn |
| Jun 30, 2024 | -480,000.00 |
| Jun 30, 2024 | -480,000.00 |
| Mar 31, 2024 | -674,000.00 |
| Mar 31, 2024 | -674,000.00 |
| Dec 31, 2023 | -2.31 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Sep 30, 2023 | -4.66 Mn |
| Jun 30, 2023 | -394,000.00 |
| Jun 30, 2023 | -394,000.00 |